# US 2013/0274891 A1 · Biomaterial and method for its realisation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0274891 A1
- Document ID: US20130274891A1
- Status: Published application
- Kind: A1
- Application number: 13/994,612
- Filed: 2010-12-14
- Published: 2013-10-17
- Earliest claimed: 2010-12-14
- Assignees: Tecres S.P.A.
- Inventors: Giovanni Faccioli; Renzo Soffiatti
- Web page: https://patentgrep.com/patent/US20130274891A1

## CPC

- A61F 2/28: Bones
- A61K 9/0024: {Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue (compositions for intravenous administration, normal injectable solutions or dispersions for, e.g. subcutaneous administration A61K9/0019; brain implants A61K9/0085; (coated) prostheses, catheters or stents A61L)}
- A61K 35/32: Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
- A61L 24/0036: {Porous materials, e.g. foams or sponges}
- A61L 24/0084: {containing fillers of phosphorus-containing inorganic compounds, e.g. apatite}
- A61L 24/06: obtained by reactions only involving carbon-to-carbon unsaturated bonds {(A61L24/043, A61L24/046 take precedence)}
- A61L 27/16: obtained by reactions only involving carbon-to-carbon unsaturated bonds
- A61L 27/46: with phosphorus-containing inorganic fillers
- A61L 27/56: Porous materials, {e.g. foams or sponges}
- A61L 2400/16: Materials with shape-memory or superelastic properties
- A61L 2430/02: for reconstruction of bones; weight-bearing implants
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)

## Abstract

Porous biocompatible composite biomaterial, useable as a drug delivery system or as spacer or as bone substitute, such as for example for filling bone lacunae or for substituting damaged parts of bone tissue, or for fixing prosthesis of various types, or for thickening bones weakened by illness such as osteoporosis or the like, including a component adapted to form a porous structural matrix and a soluble component, wherein the soluble component is in form of powder and granules or other similar agglomerates so as to have mechanical support characteristics and osteoinductive and osteoconductive characteristics in the entire volume occupied by the biomaterial, and a method for obtaining the biomaterial.

## Claims

### Claim 1

Composite biomaterial, biocompatible, useable as a drug delivery system or as spacer or as bone substitute, including for filling bone lacunae or for substituting damaged parts of bone tissue, or for fixing prosthesis of various types, or for thickening bones weakened by illness such as osteoporosis or the like, comprising a porous structural matrix component and a soluble component, wherein said soluble component is in form of powder and granules or other similar agglomerates, wherein said soluble component in form of powder has a dimension smaller than 100 microns, wherein said soluble material in form of powder, dissolving, determines the formation of empty spaces which constitute a porosity formed by microcavities with dimension smaller than 100 microns, wherein said soluble component in form of granules or other similar agglomerates has a dimension comprised between 200 and 500 microns and in that said soluble material in form of granules or other similar agglomerates, dissolving, determines the formation of empty spaces which constitute a porosity formed by macrocavities with dimension comprised between 200 and 500 microns, so as to have mechanical support characteristics and osteoinductive and osteoconductive characteristics in the entire volume occupied by said biomaterial.

### Claim 2 (depends on 1)

The biomaterial according to claim 1, wherein said porous structural matrix component comprises one or more components selected from the group comprising: polymeric components, and/or pure metal components and/or made of alloys and/or ceramic components.

### Claim 3 (depends on 1)

The biomaterial according to claim 1, wherein said soluble component comprises a calcium bioceramic inorganic material, including tricalcium phosphate and/or calcium sulphate (CS) and/or calcium carbonate (CC), and/or wherein said soluble component comprises other inorganic salts provided with solubility and biocompatibility, including sodium chloride, potassium chloride or magnesium and aluminum salts, and/or wherein said soluble component comprises soluble organic substances including polysaccharides, and/or carbohydrates.

### Claim 4 (depends on 1)

The biomaterial according to claim 1, wherein said macrocavities are substantially spherical-shaped.

### Claim 5 (depends on 1)

The biomaterial according to claim 1, wherein said biomaterial comprises radiopaque materials, comprising barium sulphate and/or other known radiopaque materials.

### Claim 6 (depends on 1)

The biomaterial according to claim 1, wherein said porous structural matrix component is in fluid or solid form.

### Claim 7 (depends on 1)

The biomaterial according to claim 1, wherein said biomaterial comprising said porous structural matrix component in fluid form is injectable.

### Claim 8 (depends on 1)

The biomaterial according to claim 1, wherein said biomaterial comprising said porous structural matrix component in solid form is a preformed shape component.

### Claim 9

Method for obtaining a biocompatible composite material useable as a drug delivery system or as spacer or as bone substitute, including for filling bone lacunae or for substituting damaged parts of bone tissue, or for fixing prosthesis of various types, or for thickening bones weakened by illness such as osteoporosis, comprising the following steps:
providing a porous structural matrix component;
providing a soluble component in form of powder and granules or other similar agglomerates;
wherein said step of providing said soluble component is attained by providing a material in form of powder with dimension smaller than 100 microns;
mixing said porous structural matrix component and said soluble component;
dissolving said soluble material in form of powder determining the formation of empty spaces which constitute a porosity formed by microcavities with dimension smaller than 100 microns;
wherein said step of providing said soluble component is attained by providing a material in form of granules or other similar agglomerates with dimension comprised between 200 and 500 microns and in that it comprises the step of dissolving said soluble material in form of granules or other similar agglomerates determining the formation of empty spaces which constitute a porosity formed by macrocavities with dimension comprised between 200 and 500 microns, so as to have mechanical support characteristics and osteoinductive and osteoconductive characteristics in the entire volume occupied by said biomaterial.

### Claim 10 (depends on 9)

The method according to claim 9, wherein said step of providing said porous structural matrix component is attained by providing one or more components selected from the group comprising: polymeric components, and/or pure metal components and/or made of alloys, and/or ceramic components.

### Claim 11 (depends on 9)

The method according to claim 9, wherein said step of providing said soluble component in form of powder and granules or other similar agglomerates is attained by providing a calcium bioceramic inorganic material, for example tricalcium phosphate and/or calcium sulphate (CS) and/or calcium carbonate (CC), and/or wherein said soluble component comprises other inorganic salts provided with solubility and biocompatibility, including sodium chloride, potassium chloride or magnesium and aluminum salts, and/or wherein said soluble component comprises soluble organic substances including polysaccharides, and/or carbohydrates.

### Claim 12 (depends on 9)

The method according to claim 9, comprising a step of thermal polymerisation or solidification or thermal sintering of said biomaterial.

### Claim 13 (depends on 9)

The method according to claim 9, comprising a step of adding radiopaque materials, including barium sulphate and/or other known radiopaque materials, to said biomaterial.

### Claim 14 (depends on 9)

The method according to claim 9, comprising a step of adding chemical active ingredients, with drug function, to said biomaterial.

### Claim 15 (depends on 14)

The method according to claim 14, wherein said adding step comprises introducing said active ingredients in solid powder form.

### Claim 16 (depends on 14)

The method according to claim 14, wherein said adding step comprises introducing said active ingredients in aqueous solution state.

### Claim 17 (depends on 3)

The biomaterial of claim 3, wherein said polysaccharides comprise lactose, and said carbohydrates comprise amides.

### Claim 18 (depends on 11)

The method of claim 11, wherein said polysaccharides comprise lactose, and said carbohydrates comprise amides.
